 |
|
|
| |
HIGH REAL-WORLD EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR (EBR/GZR) IN A HCV GENOTYPE 1 (GT1) POPULATION WITH A MIGRATION BACKGROUND
AND PREDOMINANT SUBTYPE 1B INFECTION: RESULTS FROM THE GERMAN HEPATITIS C REGISTRY (DHC-R)
|
| |
| |
Reported by Jules Levin
EASL 2019 April 10-14 Vienna
Dietrich Huppe 1, Albrecht Stoehr 2, Markus Cornberg 3, Hartwig Klinker 4, Renate Heyne 5, Christine John 6, Karl-Georg Simon 7, Manfred Bilzer 8, Veronika Guenther 9, Janina Bruening 9, Vanessa Witte 9, Claus Niederau 10
1 Gastroenterologische Gemeinschaftspraxis Herne, Herne; 2 ifi - Institute for Interdisciplinary Medicine, Study Centre St. Georg, Hamburg; 3 Hannover Medical School, Hannover; 4 University Hospital Wurzburg, Wurzburg; 5 Leberzentrum am Checkpoint, Berlin; 6 Private Practice of Internal Medicine, Berlin;
7 MVZ Dres. Eisenbach, Simon, Schwarz GbR, Leverkusen; 8 Bilzer Consulting, Munich; 9 MSD Sharp & Dohme GmbH, Haar; 10 Katholisches Klinikum Oberhausen, Oberhausen
|
| |
|
|
|
|
|
